Effects of Brexit on reimbursement decisions concerning medicinal products in Poland

Published date18 December 2018
Law FirmHogan Lovells
AuthorCelina Bujalska
Subject MatterMedical Devices,Biotechnology,Medical Reimbursement,UK,Poland,Member State,Regulatory Oversight,UK Brexit,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT